157 results on '"Brasel, Trevor"'
Search Results
2. The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection
3. Comparison of Routes of Administration, Frequency, and Duration of Favipiravir Treatment in Mouse and Guinea Pig Models of Ebola Virus Disease.
4. Animal models for COVID-19
5. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
6. Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
7. The Prophylactic and Therapeutic Efficacy of the Broadly Active Antiviral RibonucleosideN4-Hydroxycytidine (EIDD-1931) in a Mouse Model of Lethal Ebola Virus Infection
8. Natural History of Marburg Virus Infection to Support Medical Countermeasure Development
9. Lethal Factor, but Not Edema Factor, Is Required to Cause Fatal Anthrax in Cynomolgus Macaques after Pulmonary Spore Challenge
10. Performance evaluation of Puritan® universal transport system (UniTranz-RT™) for preservation and transport of clinical viruses
11. STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV)
12. Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease
13. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
14. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
15. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection
16. Mucosal Challenge Ferret Models of Ebola Virus Disease
17. Anti-IL-6 versus anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice with Potential Implications for Treating Patients Presenting with COVID-19
18. Cell-type apoptosis in lung during SARS-CoV-2 infection
19. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
20. Evaluation of fungal growth on cellulose-containing and inorganic ceiling tile
21. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation
22. Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
23. Detection of Trichothecene Mycotoxins in Sera from Individuals Exposed to Stachybotrys chartarum in Indoor Environments
24. A Cross-Disciplinary Training Program for the Advancement of Medical Countermeasures
25. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir
26. Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
27. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
28. First vaccine approval under the FDA Animal Rule
29. Antiviral effect of ranpirnase against Ebola virus
30. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation
31. Performance evaluation of two microbial transport media designed for preservation and transport of Chlamydiae, Mycoplasma and Ureaplasma
32. Performance evaluation of two universal transport media designed for preservation and transport of Chlamydiae, Mycoplasma and Ureaplasma
33. Antiviral Activity of Gendine Gloves Against Ebola Virus for Reducing Transmission in Ebola Treatment Settings
34. Detection of airborne trichothecene mycotoxins from Stachybotrys chartarum and their relationship to sick building syndrome
35. Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection
36. Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
37. Utilization of telemetry to characterize physiological changes following F. tularensis SCHU S4 aerosol infection in unvaccinated and vaccinated Cynomolgus macaques
38. Levofloxacin Cures Experimental Pneumonic Plague in African Green Monkeys
39. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)
40. Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation
41. Milestones in Progression of Primary Pneumonic Plague in Cynomolgus Macaques
42. Immune Response among Patients Exposed to Molds
43. Development of a Personal Bioaerosol Sampler Based on a Conical Cyclone with Recirculating Liquid Film
44. Immunization with Recombinant V10 Protects Cynomolgus Macaques from Lethal Pneumonic Plague
45. Influence of Impactor Operating Flow Rate on Particle Size Distribution of Four Jet Nebulizers
46. Letters to the Editor
47. Culturability and Toxicity of Sick Building Syndrome-Related Fungi Over Time
48. Detection of Trichothecene Mycotoxins in Sera from Individuals Exposed to Stachybotrys chartarum in Indoor Environments
49. Characterization of Exposure to Low Levels of Viable Penicillium chrysogenum Conidia and Allergic Sensitization Induced by a Protease Allergen Extract from Viable P. chrysogenum Conidia in Mice
50. Development of a Personal Bioaerosol Sampler Based on a Conical Cyclone with Recirculating Liquid Film.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.